Original article. Effects of telmisartan on angiotensin II-induced cardiomyocyte hypertrophy and p-ERK_1/2 phosphorylation in rat cultured cardiomyocytes

1. Baraka A, AbdelGawad H. Targeting apoptosis in the heart of streptozotocin-induced diabetic rats. J Cardiovasc Pharm Ther. 2010; 15:175-81.10.1177/1074248409356557Open DOISearch in Google Scholar

2. Quercioli A, Mach F, Montecucco F. Novel treatment strategy with direct renin inhibition against heart failure. Panminerva Med.2010; 52:41-51.Search in Google Scholar

3. Kang BY, Mehta JL. Rosuvastatin attenuates ang IImediated cardiomyocyte hypertrophy via inhibition of LOX-1. J Cardiovasc Pharm Ther .2009; 14:283-91.10.1177/1074248409344329Open DOISearch in Google Scholar

4. Zanfolin M, Faro R, Araujo EG, Guaraldo AMA, Antunes E, De Nucci G. Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats. J Cardiovasc Pharm Ther. 2006; 47:391-5.10.1097/01.fjc.0000210071.54828.9bSearch in Google Scholar

5. Frey N, Olson E N. Cardiac hypertrophy: the good, the bad and the ugly. Annu Rev Physiol. 2003; 65: 45-79.10.1146/annurev.physiol.65.092101.142243Open DOISearch in Google Scholar

6. Majak P, Bjornstad J, Vengen OA, et al. Plasma IL-18 and IL-18BP are altered differently in reverse remodeling following aortic valve replacement. Scand Cardiovasc J. 2010; 44:113-8.10.3109/14017430903426902Open DOISearch in Google Scholar

7. Tajsharghi H, Fyhr IM. Structural effects of the slow/ b-cardiac myosin heavy chain R453C mutation in cardiac and skeletal muscle. Scand Cardiovasc J. 2008; 42:153-6.10.1080/14017430701762701Open DOISearch in Google Scholar

8. van Kesteren CA, van Heugten HA, Lamers JM, et a1. Angiotensin II mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J Mol Cell Cardiol. 1997; 29:2147-57.10.1006/jmcc.1997.0448Open DOISearch in Google Scholar

9. Cohn JN, Ferrari R, Sharpe N. Cardiac remodelingconcepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf on an international forum on cardiac remodeling. J Am Coll Cardiol. 2000; 35:569-82.10.1016/S0735-1097(99)00630-0Open DOISearch in Google Scholar

10. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target. Circulation. 2004; 109:1580-9.10.1161/01.CIR.0000120390.68287.BBOpen DOISearch in Google Scholar

11. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54.10.1016/0003-2697(76)90527-3Open DOISearch in Google Scholar

12. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Mizuno T, et al. Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ Res. 1995; 77:258-65.10.1161/01.RES.77.2.2587614712Open DOISearch in Google Scholar

13. Oudit GY, Kassiri Z, Patel MP, Chappell M, Butany J, Backx PH, et a1. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res. 2007. 75: 29-39.10.1016/j.cardiores.2007.04.00717499227Open DOISearch in Google Scholar

14. Randsbaek F, Lund S, Kimose HH, Grove E, B tker HE, Schmitz O, et al. Angiotensin II inhibition increases cellular glucose transport during reperfusion but not ischemia in pig hearts. Scand Cardiovasc J. 2003; 37: 205-10.10.1080/1401743031000204012944208Open DOISearch in Google Scholar

15. Sugden PH. Signalling pathways in cardiac myocyte hypertrophy. Ann Med. 2001; 33:611-22.Search in Google Scholar

16. Zhang S, Yan Y, Daubert RA, Schnellmann RG. ERK promotes hydrogen peroxide-induced apoptosis through caspase-3 activation and inhibition of Akt in renal epithelial cells. Am J Physiol Renal Physiol. 2007; 292:F440-7.10.1152/ajprenal.00170.200616885155Search in Google Scholar

17. Wang J, Shen YH, Utama B. HCMV infection attenuates hydrogen peroxide induced endothelial apoptosis-involvement of ERK pathway. FEBS Lett. 2006; 580:2779-87.10.1016/j.febslet.2006.04.04116650413Search in Google Scholar

18. Blanc A, Pandey NR, Srivastava AK. Synchronous activation of ERK1/2, p38mapk and PKB/Akt signaling by H2O2 in vascular smooth muscle cells: potential involvement in vascular disease. Int J Mol Med. 2003; 11:229-34.Search in Google Scholar

19. Hunyady L, Tuna G. The role of the AT1 angiotensin receptor incardiac hypertrophy: angiotensin II receptor or stretch sensor. Trends Endocfinol Metab. 2004; 15: 405.10.1016/j.tem.2004.09.00315519886Search in Google Scholar

20. Zhang SQ, Ding B, Guo ZG. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II induced hypertrophic response in cultured neonatal rat cardiac myocyte. Acta Pharmacol Sin. 2004; 25:41-6.Search in Google Scholar

21. Fountoulaki K, Dimopoulos V, Giannakoulis J, Zintzaras E, Triposkiadis F. Left ventricular mass and mechanics in mild-to-moderate hypertension: Effect of nebivolol versus telmisartan. Am J Hypertens. 2005; 18:171-7.10.1016/j.amjhyper.2004.08.03915752943Open DOISearch in Google Scholar

22. Mattioli AV, Zennaro M, Bonatti S, Bonetti L, Mattioli G. Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan. Int J Cardiol. 2004; 97:383-8.10.1016/j.ijcard.2003.10.01815561322Open DOISearch in Google Scholar